4F-MDMB-BINACA Wikipedia - Versionsgeschichte

FYYRaphael am 24. Mai 2026 um 07:58 Uhr

2026-05-24T07:58:10Z

MargretBleau1 am 24. Mai 2026 um 07:21 Uhr

2026-05-24T07:21:43Z

OlaBeavers121: Die Seite wurde neu angelegt: „A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and…“

2026-05-23T07:45:10Z

Die Seite wurde neu angelegt: „A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and…“

Neue Seite

A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of ED50 values. During test sessions, both levers were active, such that ten consecutive responses on either lever led to [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] reinforcement. The substitution tests occurred only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions. The locomotor activity assay was used to identify approximate time courses and dose ranges of psychoactive effects, which is useful for identifying parameters for drug discrimination experiments and are also predictive of the time course of the psychoactive effects in human users. The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. Since there is currently no robust measure of the reinforcing/rewarding effects of cannabinoids, drug discrimination is currently the best model for assessing abuse liability of cannabinoids. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human LC separates the urine or blood sample and QTOF-MS provides high-resolution and accurate mass measurements for precise identification and structural elucidation of compounds. The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection, covering hundreds of recreational drugs, including NPS. Besides increasing the temperature to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate of air through the e-cigarette and/or add a diluent . Of all e-cigarette users registered at this forum, 7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed. Data availabili These synthetic cannabinoids act 5CL ADBA powder directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit This makes JWH-210 powder one of the most powerful compounds in its class, often used in incense blends and research settings. Our commitment to quality and customer satisfaction makes us the best place for jwh 210 buy-whether you need it for research, incense blends, or other legal applications. For qualified professionals, investing in high-quality, verified material ensures accuracy, safety, and regulatory compliance. Prioritize vendors providing full analytical validation, transparent documentation, and compliance with international controls. Value is best assessed through consistency, verifiable purity, and regulatory compliance—not cost alon Legal status Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of their subjective properties, it is necessary to set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence (Cohen et al., 2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013 As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 5CL ADBA powder headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available. Data availability When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC

← Nächstältere Version		Version vom 24. Mai 2026, 07:58 Uhr
Zeile 1:		Zeile 1:
−	In the ~~present study~~, ~~we evaluated~~ the ~~neurotoxicity~~ of ~~two~~ synthetic cannabinoids (JWH-081 and JWH-210~~) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses~~ (~~0.1, 1,~~ 5 mg/kg<br><br><br>~~High resolution mass spectrometry such as LC-QTOF-MS allows the detection~~ and ~~identification~~ of ~~a broad spectrum of recreational drugs~~, ~~including new psychoactive substances~~. ~~A point-~~of~~-care drugs~~ of ~~abuse (DOA) test was initially performed on~~ the ~~urine~~ of ~~the patient~~. ~~He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep~~, ~~Turkey 10 seconds before~~ the ~~onset~~ of ~~his first symptoms~~. ~~He usually smokes a pack~~ of ~~cigarettes a day~~ and ~~sometimes smokes e-cigarettes. Combined with non-specific~~, ~~transient symptoms, clinical recognition of SCRA intoxication is challenging .~~<br>~~Data availability~~ <br>~~The intensity is plotted against the retention time for both chromatograms~~, ~~demonstrating the [https://cannabinoidsrc4f-adb~~.~~com/~~ 5CL ADBA powder~~] presence~~ and ~~elution profiles~~ of ~~nicotine and ADB-BUTINACA~~ in ~~the analysed vape liquid sample~~. ~~LC-QTOF-MS Chromatograms of Nicotine~~ (~~Top~~) ~~and ADB-BUTINACA~~ (~~Bottom~~) in ~~the Vape Liquid used by the patient~~. The LC-~~QTOF~~-~~MS analysis showed that the e~~-~~liquid contained nicotine~~ and ~~ADB~~-~~BUTINACA~~ (~~Fig~~. 1). ~~Because the point-of-care DOA test~~ is ~~generally not able to detect synthetic recreational drug substances~~, ~~the~~ liquid ~~of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry~~ (~~LC-QTOF-MS~~) ~~on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER~~, ~~the nausea complaints of the patient were reduced and the patient was discharged hom~~<br><br><br>~~A limitation~~ of ~~this case report is that we did not have a urine sample available for additional NPS testing~~. ~~Point-~~of~~-care DOA tests~~ using ~~urine to screen for misuse of multiple substances~~, ~~regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone~~. ~~THC~~, ~~methamphetamine, SRCA, lysergic acid diethylamide~~ (~~LSD~~)~~, gamma~~-~~hydroxybutyrate (GHB)~~ and ~~ketamine are likely to become volatile under~~ the ~~temperature~~ of ~~current e-cigarettes~~, ~~while crack cocaine is hard to vaporise~~. ~~A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 %~~ of ~~the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours~~<br><br><br>The ~~current~~ study ~~indicates that the test compounds produce locomotor depression similar~~ to ~~that of Δ9-THC, and fully substitute for~~ the ~~discriminative stimulus effects~~ of ~~Δ9-THC. In summary, these~~ 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA ~~have similar abuse liability as Δ9-tetrahydrocannabinol~~ and ~~should be controlled in a similar fashion. Much of the in vivo 5CL ADBA powder testing of the synthetic cannabinoid compounds have been pre~~-~~clinical studies focused on their cannabinoid-like effects or like~~ the ~~present study, focused on their abuse liability. There is indication~~ that ~~at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and~~ a compound ~~from the present study~~, 5F-~~MDMB~~-~~PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al~~.~~, 2016<br><br><br>Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than the 4F~~-~~MDMB-BINACA, indicating monohydroxylation at~~ the ~~butyl side chain (B19/B21)~~ and ~~indazole~~ (~~B23/B25) moieties with product ions m/z 145 and 161, respectively~~. ~~Metabolites identified at m/z 366 (B8, B9, B13~~)~~, which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis~~. ~~Death involving these drugs have been reported [5~~,6,7,~~8,9]~~, and ~~this raises public health and social concerns. Due to their similar physiological~~ effects ~~to the principal psychoactive component of cannabis~~, ~~Δ9-tetrahydrocannabinol (THC~~)~~, SCBs are gaining popularity and are often abused as recreational drugs~~. ~~The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in the postmortem blood samples of both victims suggests that both substances played a role in the fatal outcom~~<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 5CL ADBA powder headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly ~~availabl~~	+	Only 3/20 urine samples were identified with the parent drug, 4F-MDMB-BINACA, highlighting the risk of analysing only parent ions and emphasizing the importance of metabolite identification in the forensic and clinical settin<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial.<br>About Powder JWH-2<br><br><br>Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017<br><br>Fig. 2. <br>Separation of compounds was performed on a 2.1 mm×100 mm, 1.7 5CL ADBA powder μm particle size ACQUITY Torus™ DIOL analytical column (Waters) with guard cartridge. Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters) coupled with a Xevo TQ-S Triple Quadrupole Mass Spectrometer (Waters). During the death scene examination, multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles, an unopened box of nebivolol-containing drug, and 18 g of unrecognizable herbal residue in a cigarette box.<br>Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur<br><br><br>Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in the nucleus accumbens core region. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity.<br>Table of Conten<br><br>4. Drugs <br>The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in humans. Drug discrimination is a well-known animal model of the subjective effects of drugs and correlates well with abuse liability (Young 2009; Horton et al. 2013). Assessment of abuse liability is based on several factors, including chemical structure, pharmacological mechanism of action, and finally, subjective and reinforcing behavioral effects (FDA, 2010; Swedberg, 2013).<br>Michael B Gat<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 5CL ADBA powder headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available.<br>Data availability <br>When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC

← Nächstältere Version		Version vom 24. Mai 2026, 07:21 Uhr
Zeile 1:		Zeile 1:
−	~~A 30~~-~~min period~~, ~~beginning when maximal depression~~ of ~~locomotor activity first appeared as~~ a ~~function~~ of ~~dose~~, was ~~used for analysis~~ of ~~dose~~-~~response data~~ and ~~calculation~~ of ~~ED50 values~~. ~~During test sessions,~~ both ~~levers were active~~, ~~such that ten consecutive responses on either lever led to~~ [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] ~~reinforcement. The substitution tests occurred only if the rats had achieved 85% injection~~-~~appropriate responding on~~ the ~~two prior training sessions~~.~~<br>The locomotor activity assay was used to identify approximate time courses and dose ranges~~ of ~~psychoactive effects, which is useful for identifying parameters for drug discrimination experiments~~ and ~~are also predictive of~~ the ~~time course of~~ the ~~psychoactive effects in human users~~. The ~~purpose~~ of ~~the present study was~~ to ~~assess~~ the ~~abuse liability~~ of 5F-~~MDMB~~-~~PINACA, MDMB~~-~~CHIMICA, MDMB~~-~~FUBINACA, ADB~~-~~FUBINACA, and AMB~~-~~FUBINACA~~. ~~Since there is currently no robust measure of~~ the ~~reinforcing/rewarding effects of cannabinoids~~, ~~drug discrimination is currently~~ the ~~best model for assessing abuse liability~~ of ~~cannabinoids. The findings produce an apparent paradox, since CPP~~ and ~~self-administration predict with high reliability~~ the ~~likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human~~<br><br><br>~~LC separates the~~ urine ~~or blood~~ sample ~~and QTOF-MS provides high-resolution and accurate mass measurements~~ for ~~precise identification and structural elucidation of compounds~~. ~~The LC~~-~~QTOF~~-~~MS method offers a more comprehensive and sensitive approach~~ for ~~drug detection~~, ~~covering hundreds of recreational drugs~~, ~~including NPS~~. ~~Besides increasing~~ the temperature ~~to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate~~ of ~~air through the~~ e-~~cigarette and/or add a diluent . Of all e-cigarette users registered at this forum~~, 7.~~8 % vaped SCRAs . About 15~~ % of ~~individuals registered~~ at ~~forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens~~ to ~~the new psychoactive substances (NPS) that are currently developed at high speed.~~<br>~~Data availabili~~<br><br><br>These synthetic cannabinoids act 5CL ADBA powder directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC~~, different metabolism~~, and ~~often greater toxicity (Fantegrossi et al., 2014). Discriminative~~ stimulus effects ~~were tested in rats trained to discriminate~~ Δ9-~~tetrahydrocannabinol (3 mg/kg~~, ~~30-min pretreatment).~~ 5F-MDMB-PINACA ~~(also known as 5F-ADB, 5F-ADB-PINACA)~~, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA ~~(also known~~ as ~~FUB~~-~~AMB, MMB-FUBINACA) were tested for~~ in vivo cannabinoid-like effects ~~to assess~~ their abuse ~~liabilit<br><br><br>This makes JWH-210 powder one~~ of the ~~most powerful compounds in its class, often used in incense blends~~ and ~~research settings~~. ~~Our commitment to quality~~ and ~~customer satisfaction makes us~~ the ~~best place for jwh 210 buy~~-~~whether you need it for research, incense blends, or other legal applications. For qualified professionals, investing in high~~-~~quality~~, ~~verified material ensures accuracy~~, ~~safety, and regulatory compliance. Prioritize vendors providing full analytical validation, transparent documentation, and compliance with international controls~~. ~~Value is best assessed through consistency, verifiable purity~~, ~~and regulatory compliance—not cost alon~~<br><br>~~Legal status~~ <br>~~Briefly~~, the ~~FOB test was comprised of several behavioral changes including catalepsy~~, ~~traction~~, ~~tremor~~, ~~convulsion~~, ~~exopthalmos~~, ~~piloerection~~, ~~salivation~~, ~~lacrimation~~, ~~diarrhea~~, ~~skin coloration~~, ~~pinna reflex, righting reflex~~, and ~~death~~. ~~The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of~~ their ~~subjective properties, it is necessary~~ to ~~set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting~~ the ~~possibility~~ of ~~their neurotoxicity with no scientific evidence (Cohen et al.~~, ~~2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013<br><br><br>As synthetic cannabinoid receptor agonists~~ (~~SCRA~~) are gaining popularity ~~globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests~~. ~~He confirmed~~ that ~~he had been vaping an electronic cigarette (e~~-~~cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7)~~ and ~~respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance~~ detected~~, while~~ in ~~seven other~~ substances ~~of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali~~<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 5CL ADBA powder headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available.<br>Data availability <br>When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC	+	In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours<br><br><br>The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo 5CL ADBA powder testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than the 4F-MDMB-BINACA, indicating monohydroxylation at the butyl side chain (B19/B21) and indazole (B23/B25) moieties with product ions m/z 145 and 161, respectively. Metabolites identified at m/z 366 (B8, B9, B13), which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9], and this raises public health and social concerns. Due to their similar physiological effects to the principal psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), SCBs are gaining popularity and are often abused as recreational drugs. The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in the postmortem blood samples of both victims suggests that both substances played a role in the fatal outcom<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 5CL ADBA powder headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl